Diassess wins $21.9M federal contract for home flu test

Diassess was awarded a federal contract worth up to $21.9 million to develop an at-home flu diagnostic test.

The five-year partnership with the Biomedical Advanced Research and Development Authority will also accelerate Diassess’ development of its professional flu diagnostic for the clinic, the company said in a statement.

The separate, consumer-focused test will include a smartphone app that will link users to treatment options. The company said the funding, with its total subject to options exercised by BARDA, will be enough to take both tests through clinical trials and submissions for FDA clearance.

Read the full story at Fierce Biotech